-
ENDRA Life Sciences Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
Mar 26, 2020
ANN ARBOR, MI / ACCESSWIRE / March 26, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today provided a business update and repo...read more > -
ENDRA Life Sciences Provides Update on FDA Regulatory Timeline
Mar 19, 2020
Company guides to Q2:20 submission of 510(k) with robust filing package...read more > -
ENDRA Life Sciences Provides European Commercialization Update
Mar 17, 2020
Executing Tactical Elements of EU Commercial Plan to Support Initial Launch Activities...read more > -
ENDRA Life Sciences Receives CE Mark for its TAEUS(R) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease
Mar 10, 2020
First regulatory clearance paves the way to commercialize TAEUS in European markets U.S. FDA submission expected during H1:20...read more > -
ENDRA Life Sciences to Host Fourth Quarter 2019 Financial Results Conference Call and Webcast on Thursday, March 26, 2020 at 4:30 p.m. ET
Mar 9, 2020
ANN ARBOR, MI / ACCESSWIRE / March 9, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today announced that its fourth quarter fina...read more > -
ENDRA Life Sciences Granted Chinese Patent for "Thermoacoustic Imaging Probe"
Mar 6, 2020
Newly Issued Patent Protects ENDRA's Innovative Design for its Fatty Liver Imaging Probe (FLIP) in China...read more > -
Dr. Raza Malik joins ENDRA Life Sciences as Scientific Advisor
Mar 3, 2020
ANN ARBOR, MI / ACCESSWIRE / March 3, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today announced the appointment of Raza Mali...read more > -
ENDRA Life Sciences Renews GE Healthcare Collaboration Agreement
Jan 15, 2020
Supports Commercialization of TAEUS Liver Product Targeting NAFLD-NASH...read more >
